These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36815334)

  • 21. Is the USA on track to end the HIV epidemic?
    Guilamo-Ramos V; Thimm-Kaiser M; Benzekri A
    Lancet HIV; 2023 Aug; 10(8):e552-e556. PubMed ID: 37541707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine HIV screening in North Carolina in the era of the Affordable Care Act: update on laws, reimbursement, and tests.
    White BL; Carter YL; Records K; Martin IB
    South Med J; 2013 Nov; 106(11):637-41. PubMed ID: 24192596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals.
    Jenness SM; Johnson JA; Hoover KW; Smith DK; Delaney KP
    AIDS; 2020 Nov; 34(14):2103-2113. PubMed ID: 32910062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability of Sexually Transmitted Disease and HIV Clinical Services: Ending the HIV Epidemic Versus Non-Ending the HIV Epidemic Jurisdictions, 2018.
    Leichliter JS; Cuffe KM; Kelley KR; Gift TL
    Sex Transm Dis; 2022 Jan; 49(1):e13-e16. PubMed ID: 34030153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Determinants of Black MSM HIV Testing Coverage (2011-2016).
    Tempalski B; Beane S; Cooper HLF; Friedman SR; McKetta SC; Ibragimov U; Williams LD; Stall R
    AIDS Behav; 2020 Sep; 24(9):2572-2587. PubMed ID: 32124108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.
    Krebs E; Zang X; Enns B; Min JE; Behrends CN; Del Rio C; Dombrowski JC; Feaster DJ; Gebo KA; Marshall BDL; Mehta SH; Metsch LR; Pandya A; Schackman BR; Strathdee SA; Nosyk B;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S301-S311. PubMed ID: 32877548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.
    Morne JE; Tesoriero JM; Martin EG; Birkhead GS; Holtgrave DR; Hagos K; Zucker H
    Public Health Rep; 2020; 135(1_suppl):65S-74S. PubMed ID: 32735198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foretelling the Future: Predicting STI Diagnosis and Its Implications for Ending the HIV Epidemic among Black Men Who Have Sex with Men.
    Burns PA; Mena LA; Crosby RL
    J Urban Health; 2020 Oct; 97(5):642-652. PubMed ID: 31898202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ending the HIV Epidemic: What Will Happen to the HIV Testing Workforce?
    Green NC
    Am J Public Health; 2022 Apr; 112(4):586-587. PubMed ID: 35319922
    [No Abstract]   [Full Text] [Related]  

  • 31. The Time Is Now to End the HIV Epidemic.
    Giroir BP
    Am J Public Health; 2020 Jan; 110(1):22-24. PubMed ID: 31725312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress and Challenges in Ending HIV and AIDS in Australia.
    Holt M
    AIDS Behav; 2017 Feb; 21(2):331-334. PubMed ID: 28004219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the reliability of the CD4 depletion model in the presence of Ending the HIV Epidemic initiatives.
    Tang ME; Goyal R; Anderson CM; Mehta SR; Little SJ
    AIDS; 2023 Aug; 37(10):1617-1624. PubMed ID: 37260256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities.
    Kim JYH; Barth SK; Monroe AK; Ahsan S; Kovacic J; Senn S; Castel AD
    Expert Rev Anti Infect Ther; 2023; 21(8):831-846. PubMed ID: 37470436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
    Finlayson T; Cha S; Xia M; Trujillo L; Denson D; Prejean J; Kanny D; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(27):597-603. PubMed ID: 31298662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential contribution of PrEP uptake by adolescents 15-17 years old to achieving the "Ending the HIV Epidemic" incidence reduction goals in the US South.
    Hamilton DT; Wang LY; Hoover KW; Smith DK; Delaney KP; Li J; Hoyte T; Jenness SM; Goodreau SM
    PLoS One; 2023; 18(11):e0288588. PubMed ID: 37943869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stakeholder Perspectives on MAPS.
    Sanchez AL; Hoskins K; Pettit AR; Momplaisir F; Gross R; Brady KA; Hoffacker C; Zentgraf K; Beidas RS
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S190-S196. PubMed ID: 35703771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supporting the Growth of Domestic HIV Implementation Research in the United States Through Coordination, Consultation, and Collaboration: How We Got Here and Where We Are Headed.
    Mustanski B; Smith JD; Keiser B; Li DH; Benbow N
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S1-S8. PubMed ID: 35703749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Changing Landscape of HIV Prevention in the United States: Health Department Experiences and Local Adaptations in Response to the National HIV/AIDS Strategy and High-Impact Prevention Approach.
    Fisher HH; Essuon A; Hoyte T; Shapatava E; Shelley G; Rios A; Beane S; Bourgeois S; Dunbar E; Sapiano T
    J Public Health Manag Pract; 2018; 24(3):225-234. PubMed ID: 28492452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.